| Naresh Julka, MD | |
|
2340 S Highland Ave Ste 160, Lombard, IL 60148 | |
| (630) 495-9356 | |
| (630) 495-3770 |
| Full Name | Naresh Julka |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 2340 S Highland Ave Ste 160, Lombard, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699772608 | NPI | - | NPPES |
| 036052010 | Medicaid | IL | |
| 1616108 | Other | IL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 036052010 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Naresh Julka, MD 120w 22nd St S-200, Oak Brook, IL 60523-1557 Ph: (630) 974-5240 | Naresh Julka, MD 2340 S Highland Ave Ste 160, Lombard, IL 60148 Ph: (630) 495-9356 |
News Archive
Findings from three large, randomized Phase III studies demonstrate the superiority of Tasigna (nilotinib) compared to Glivec (imatinib) at achieving deeper molecular responses across various Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) patient populations, including newly diagnosed patients, patients with residual disease who switched to Tasigna after long-term treatment with Glivec, and patients who failed to respond to frontline Glivec (as defined by 2013 European LeukemiaNet [ELN] guidelines).
IsoRay, Inc. announced, today, it has completed an initial feasibility study, which demonstrates the ability to use its patented Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy) in accelerated partial breast irradiation (APBI) for breast cancer treatment.
Mayo Clinic researchers have identified critical steps leading to myelin destruction in neuromyelitis optica (NMO), a debilitating neurological disease that is commonly misdiagnosed as multiple sclerosis (MS). The findings could lead to better care for the thousands of patients around the world with NMO. The paper was published in the journal, Proceedings of the National Academy of Sciences, USA.
A new study published today in the journal Blood has identified a protein that could diagnose chronic graft-versus-host disease (cGvHD), a serious, long-term complication that affects some patients after a blood and bone marrow transplant.
Researchers have developed a novel treatment that could block the development of Alzheimer's disease using microscopic droplets of fat to carry drugs into the brain.
› Verified 5 days ago
Dr. Diane Gale Rapaport, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 580 Waters Edge, Suite 100, Lombard, IL 60148 Phone: 630-495-8484 Fax: 630-495-1598 | |
Rong Shang Tu, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2340 S Highland Ave, 230, Lombard, IL 60148 Phone: 630-932-2040 Fax: 866-932-1513 | |
Dr. Nasser A Boshra, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1801 S Highland Ave Ste 130, Lombard, IL 60148 Phone: 630-627-4722 Fax: 630-627-9134 | |
Shawn George, DO Nephrology Medicare: Medicare Enrolled Practice Location: 500 E. 22nd Street, Suite A, Lombard, IL 60148 Phone: 630-932-2055 Fax: 630-932-2059 | |
Julia C Andreoni, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1801 S Highland Ave, Ste 130, Lombard, IL 60148 Phone: 630-627-4722 | |
Ninel Kandel, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 130 S Main St Ste 201, Lombard, IL 60148 Phone: 331-221-9001 Fax: 331-221-3957 | |
Dr. Laura U Vetrone, MD. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 130 S Main St Ste 201, Lombard, IL 60148 Phone: 331-221-9001 |